Lind Nanna, Christensen Merete Bechmann, Nørgaard Kirsten
Copenhagen University Hospital - Steno Diabetes Center Copenhagen, Herlev, Denmark.
Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen N, Denmark.
PEC Innov. 2024 Jul 15;5:100324. doi: 10.1016/j.pecinn.2024.100324. eCollection 2024 Dec 15.
The lack of descriptions for education programs in studies evaluating the efficacy of continuous glucose monitoring (CGM) compared to blood glucose monitoring (BGM) for individuals with T2DM makes it difficult to compare results across trials. This study aimed to develop and evaluate a new education program for adults with insulin-treated T2DM and HbA1c ≥58 mmol/mol (7.5 %) initiating CGM.
A 3-h education program was created to provide information on diabetes self-management and CGM or BGM based on international guidelines and a pre-evaluation based on user needs assessment. Questionnaires were used to post-evaluate participant-rated benefits from the program.
Seven individuals attended a user needs assessment of the program and 96 participated in the final education program (61.5 % men, mean age 61 (59.5;63) years, mean diabetes duration 18.2 (16.9;19.5) years, and median HbA1c 69 (63-78)mmol/mol (8.5 (7.9-9.3)%). Benefit from this program was rated good/very good by 95.5 % with no statistically significant difference between glucose monitoring groups.
This study presents a new well-received education program for T2DM for both the CGM and BGM group.
The description of the development process and the education provided for both glucose monitoring groups may be useful for CGM initiation in clinics and trials.
在评估持续葡萄糖监测(CGM)与血糖监测(BGM)对2型糖尿病(T2DM)患者疗效的研究中,缺乏对教育项目的描述,这使得难以在各试验间比较结果。本研究旨在为开始使用CGM的胰岛素治疗的T2DM且糖化血红蛋白(HbA1c)≥58 mmol/mol(7.5%)的成年人开发并评估一种新的教育项目。
基于国际指南并根据用户需求评估创建了一个3小时的教育项目,以提供糖尿病自我管理以及CGM或BGM的相关信息。通过问卷调查对参与者对该项目的评价益处进行事后评估。
7人参与了该项目的用户需求评估,96人参加了最终的教育项目(男性占61.5%,平均年龄61(59.5;63)岁,平均糖尿病病程18.2(16.9;19.5)年,HbA1c中位数为69(63 - 78)mmol/mol(8.5(7.9 - 9.3)%)。95.5%的人对该项目的益处评价为好/非常好,血糖监测组之间无统计学显著差异。
本研究为CGM组和BGM组的T2DM患者提供了一个新的、广受好评的教育项目。
对开发过程的描述以及为两个血糖监测组提供的教育内容可能对临床和试验中启动CGM有用。